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Abstract background Home-based HIV counselling and testing (HBHCT) has the potential to increase HIV
testing uptake in sub-Saharan Africa (SSA), but data on linkage to HIV care after HBHCT are scarce.
We conducted a systematic review of linkage to care after HBHCT in SSA.
methods Five databases were searched for studies published between 1st January 2000 and 19th
August 2016 that reported on linkage to care among adults newly identified with HIV infection
through HBHCT. Eligible studies were reviewed, assessed for risk of bias and findings summarised
using the PRISMA guidelines.
results A total of 14 studies from six countries met the eligibility criteria; nine used specific
strategies (point-of-care CD4 count testing, follow-up counselling, provision of transport funds to
clinic and counsellor facilitation of HIV clinic visit) in addition to routine referral to facilitate linkage
to care. Time intervals for ascertaining linkage ranged from 1 week to 12 months post-HBHCT.
Linkage ranged from 8.2% [95% confidence interval (CI), 6.8–9.8%] to 99.1% (95% CI, 96.9–
99.9%). Linkage was generally lower (<33%) if HBHCT was followed by referral only, and higher
(>80%) if additional strategies were used. Only one study assessed linkage by means of a randomised
trial. Five studies had data on cotrimoxazole (CTX) prophylaxis and 12 on ART eligibility and
initiation. CTX uptake among those eligible ranged from 0% to 100%. The proportion of persons
eligible for ART ranged from 16.5% (95% CI, 12.1–21.8) to 77.8% (95% CI, 40.0–97.2). ART
initiation among those eligible ranged from 14.3% (95% CI, 0.36–57.9%) to 94.9% (95% CI, 91.3–
97.4%). Additional linkage strategies, whilst seeming to increase linkage, were not associated with
higher uptake of CTX and/or ART. Most of the studies were susceptible to risk of outcome
ascertainment bias. A pooled analysis was not performed because of heterogeneity across studies with
regard to design, setting and the key variable definitions.
conclusion Only few studies from SSA investigated linkage to care among adults newly diagnosed
with HIV through HBHCT. Linkage was often low after routine referral but higher if additional
interventions were used to facilitate it. The effectiveness of linkage strategies should be confirmed
through randomised controlled trials.
keywords HIV/AIDS, home-based HIV counselling and testing, linkage to care, Uganda
Introduction
Access to antiretroviral therapy (ART) in sub-Saharan
Africa (SSA) has expanded considerably, but AIDS-
related mortality remains high [1]. A major cause of this
mortality is the late presentation of patients for treatment
[2]. Early ART initiation is dependent on early HIV diag-
nosis, and prompt linkage to and retention in care [3].
HIV counselling and testing (HCT) is essential in expand-
ing HIV prevention and treatment services [4]. However,
HCT uptake in SSA remains low [5]. For instance, the
proportion of HIV-positive adults in SSA who are awareaSee Appendix for the Working Group on Linkage to HIV Care.
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of their HIV status has been estimated to be only 60%
[6]. In order to expand access to HIV testing in settings
with generalised HIV epidemics, WHO recommends
community-based HCT with linkage to prevention, care
and treatment services, in addition to facility-based HCT
[7].
In the community-based HCT model, services are deliv-
ered through mobile, workplace-, school- and home-
based approaches thus removing structural, logistical and
social barriers to HCT [8]. Community-based HCT may
also be delivered as part of multidisease campaigns that
involve intensive community mobilisation lasting 1–
2 weeks followed by mobile HIV testing, often coupled
with other preventive medical services (campaign HCT)
[9].
Under the home-based HIV counselling and testing
(HBHCT) approach, HCT services are conducted by
trained HCT service providers in the client’s home [10].
HBHCT may be provided to everyone in a community
through a door-to-door approach or to household mem-
bers of known tuberculosis (TB) or HIV-positive patients
[4, 10]. According to WHO, there were at least 39
HBHCT programmes in 10 SSA countries by early 2011
[10]. A systematic review published the following year
found 21 studies that had reported on the uptake of
HBHCT in SSA [11]. As then, several studies have
reported successful implementation of HBHCT in rural
[12–24] and urban [19, 23] populations in SSA. HBHCT
is highly acceptable and has the potential to substantially
increase HIV testing uptake in SSA [11]. It is cost effec-
tive at reaching previously untested persons compared
with other HCT models in settings with high HIV preva-
lence [25, 26], promotes equitable access of services [27]
and may help to promote HCT among couples [28] and
prevention of mother-to-child HIV transmission [29].
Importantly, HBHCT facilitates early HIV diagnosis and
therefore provides an opportunity for early linkage to
care [29]. These attributes highlight the potential of
HBHCT as an effective platform for HIV prevention and
population-based test-and-treat strategies.
Despite these advantages, few data are available on
linkage to care after HBHCT particularly among newly
identified HIV-positive persons or on the effectiveness of
strategies to increase linkage after HCT [30]. In the
absence of interventions to facilitate linkage to care, indi-
viduals that test HIV positive through HBHCT may find
it more challenging to enter care compared with those
identified in facility-based HCT [31]. This is because
HBHCT is more likely to reach socio-economically disad-
vantaged populations that have difficulty accessing
healthcare services compared with facility-based HCT
[32]. In order to identify effective linkage strategies, data
are specifically required on linkage to care soon after
HBHCT. The reasons for this include the current WHO
recommendation to initiate ART among all HIV-positive
adults regardless of WHO clinical stage and at any CD4
count [33]; increasing use of HBHCT in Africa; and
growing importance of early treatment for improved clin-
ical outcomes [34–36] and HIV prevention [37]. A recent
systematic review on linkage to care following commu-
nity- and facility-based HCT [9] included 10 HBHCT
studies but did not distinguish linkage outcomes between
HBHCT and campaign HCT, between newly and previ-
ously diagnosed HIV-positive individuals, or between
children/adolescents and adults. Individuals who previ-
ously tested HIV-positive and have not yet linked to care
are likely to differ from newly identified patients with
regard to barriers that may prevent service uptake [12].
Similarly linkage to care among children/adolescents may
be influenced by factors that are unique to this popula-
tion [38, 39].
The specific objectives of our review were to estimate
the proportion of individuals in SSA linking to care
within 12 months among those who were newly diag-
nosed with HIV; the proportion initiating daily cotrimox-
azole (CTX) prophylaxis (i.e. the people who initiated
daily CTX prophylaxis among those who linked to care
and were eligible for CTX); and the proportion initiating
ART (i.e. the people who initiated ART among those
who linked to care and were eligible for ART); and to
summarise data on the strategies that have been used to
increase linkage to care after HBHCT.
Methods
Search strategy
We searched five databases (Medline, Embase, Global
Health, Web of Science, and Africa-Wide information)
for studies published between 1st January 2000 (time at
which roll-out of ART programmes began in SSA [11])
and 19th August 2016. The following key terms were
used as follows: (HIV diagnosis OR HIV voluntary coun-
selling and testing OR HIV testing and counselling OR
HIV counselling and testing) AND (home based OR
mobile OR community OR household OR door-to-door
OR survey) AND (linkage OR access OR uptake OR
enrolment OR non-enrolment OR retention OR loss to
follow-up OR loss to care OR care OR treatment OR
pre-antiretroviral therapy) AND (Africa OR individual
names of countries in SSA). No language restriction was
applied to the literature search. Identified articles were
exported using Endnote reference management software
and duplicate articles removed. Two authors (ER and SB)
808 © 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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independently screened titles and abstracts of articles to
identify eligible publications, discussed inconsistencies
and reached a consensus on their eligibility. Studies were
eligible if they were conducted in SSA, and had original
data on linkage to care among adults (≥18 years) newly
identified with HIV infection through HBHCT, defined as
HCT services offered in an individual’s home. Studies
whose study populations included persons <18 years were
eligible, but only data for participants aged ≥18 years
were utilised to estimate linkage and other outcomes.
Studies for which the required information was not pub-
lished but might have been collected were identified and
the corresponding authors approached with requests for
additional data. Where two or more eligible articles
reported on similar or overlapping populations, the arti-
cle with the most complete data was included. Review
articles were excluded, but their bibliographies as well as
those of the identified articles were manually checked to
identify any additional studies. Conference abstracts were
excluded. All potentially eligible papers were then sub-
jected to full-text screening.
Data extraction and synthesis
A data extraction form was used to collect the following
information from each eligible article: first author’s name,
publication year, country and setting where study was
conducted, study population, sample size, study design,
definition of linkage to care, strategies used to promote
and time for evaluation of linkage to care. We also
obtained the number of HIV-positive adults who were
newly diagnosed, and, among those, the numbers who
linked to care (as defined in the respective studies), and
were eligible for, and initiated, CTX prophylaxis and
ART (based on national guidelines that were in use at the
time of the respective studies). Risk of bias in the
included studies was assessed using a component
approach, similar to the Cochrane Collaboration’s [40],
and based on three items: selection bias, outcome ascer-
tainment and attrition. The results were summarised
using the PRISMA guidelines [41].
We used the reported data to calculate the proportions
[and their 95% confidence intervals (CI), using the Clop-
per–Pearson method] who linked to care, initiated CTX
prophylaxis, were eligible for and initiated ART. The
denominator for linkage was all newly diagnosed HIV-
positive adults (≥18 years) who had a potential minimum
follow-up period corresponding to the time point when
linkage was assessed (i.e. including those who out-
migrated, died, or were lost to follow-up, but excluding
those who entered the study at a later date so had a shorter
potential follow-up period). We did not stratify our linkage
estimates by individual-level factors that may potentially
influence referral uptake, such as HIV disease stage or
CD4 count at the time of HIV diagnosis, as these data were
not available for most of the studies. However, we com-
pared linkage estimates between studies conducted under
different CD4 ART eligibility thresholds, that is ≤250 cells/
ll vs. ≤350 cells/ll. The denominator for ART eligibility
was all individuals who linked within the specified time
period, and those for initiation of CTX prophylaxis and
ART were all individuals who linked and were eligible for
CTX and ART, respectively. We did not perform a meta-
analysis because the identified studies varied widely with
regard to design, setting, definition of linkage to care, the
time points of and method for ascertaining linkage, and
with regard to the strategies used to facilitate linkage.
Results
Summary of search results
The search identified 5905 articles of which 61 were sub-
jected to full-text screening (Figure 1). Of those screened,
21 were eligible for detailed review; two were excluded
on the basis of reporting on overlapping study popula-
tions [20, 42]. Of the remaining 19 articles, one [19] had
all the required data. Additional data were obtained for
13 [12–14, 18, 21–24, 43–47] of the remaining 18 arti-
cles after contacting the respective corresponding authors.
Thus, 14 studies were included in the review. A summary
description of the included studies is presented in
Table 1. The studies were conducted in six countries,
that is Uganda [13, 14, 43, 44], South Africa [13, 14, 18,
23, 24, 45], Kenya [12, 19], Malawi [46, 47], Lesotho
[22] and Swaziland [21] between 2005 and 2015. Most
(92%) studies were based in rural [12–14, 18, 21, 22,
24, 43, 45, 47] or semirural settings [44, 46] settings;
two were conducted in both rural and urban [19, 23]
populations. The number of newly identified HIV-positive
adults varied widely across studies (range: 15–1637).
Summary of study objectives and populations
The included studies aimed to assess acceptability of
HBHCT [18, 19, 21–24, 46, 47], and HIV prevalence
[19], linkage to care [12–14, 18, 19, 21–24, 43–45],
uptake of ART [13, 14, 18, 24, 44, 47], and viral sup-
pression [13, 14, 18], in the context of HBHCT. Two
studies compared HBHCT and mobile HCT with regard
to uptake and cost of HCT, HIV positivity rates and link-
age to care [21, 22]. Three observational studies [13, 18,
44] and one randomised trial [14] were designed to eval-
uate the effect of specific interventions on linkage to HIV
© 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 809
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care, uptake of ART and other outcomes. Except for one
study in which HBHCT was provided to household con-
tacts of TB index patients [23], all the other studies used
the door-to-door HBHCT approach. Study participants
mostly comprised individuals aged ≥13 years. However,
two studies also recruited children (<13 years) [19, 21].
With the exception of two studies that recruited newly
identified HIV-positive individuals [22, 23], participants
in other studies were a mixture of previously and newly
identified HIV-positive patients.
Risk of bias
Only two [13, 18] studies had a low risk of bias for all
assessed items (Table 2). Risk of selection bias was low
(≥80% HBHCT coverage) in four studies [13, 18, 19,
44]. Risk of attrition bias was low (≥80% participant
retention) in eight [13, 14, 18, 23, 24, 44–46] of 10 stud-
ies in which participants were followed. Self-reported
linkage to care was confirmed by tracking referrals and
review of records at the referral clinic in only two studies
[43, 45]. In the first study [43], no information was
reported on the proportion of participants for whom
clinic records were not found. In the second study [45],
clinic records were found for only 71% of the tracked
referrals, and self-reported data were used to ascertain
linkage for the rest of the participants. Self-reported link-
age to care was confirmed by review of documentation
issued to patients by HIV clinics (e.g. clinic cards) in
three studies [13, 14, 18]; linkage was not verified with
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the HIV clinics. In five studies [12, 21, 22, 24, 47], ascer-
tainment of linkage to care was based on data from HIV
clinics in the areas where the studies were conducted;
participants who may have linked to HIV clinics outside
of the study areas were not tracked. Only self-reported
data were used in the rest of the studies [19, 23, 44, 46].
Linkage to HIV care
In all studies, persons who tested HIV positive were
referred for care. Additional strategies to facilitate linkage
to care were used in nine (64%) [13, 14, 18, 22, 24, 43–
46] of the studies (Table 1). These strategies included:
provision of funds for transport to the HIV clinic [46];
follow-up counselling [13, 14, 18, 24, 43–45]; lay coun-
sellor facilitation of the initial HIV clinic visits (the coun-
sellor met the HIV-positive participant at the clinic and
explained the clinic processes and the benefits of ART)
[14]; point-of-care (POC) CD4 count [13, 14, 18, 22]
and home-based collection of samples for viral load [13]
testing and provision of results. Linkage to care was
ascertained within 3 months of HBHCT in 50% of stud-
ies [12, 19, 22, 23, 44–46]. Ascertainment of linkage in
the remaining studies was carried out >3 to 6 [18, 21,
43] and >6 to 12 [13, 14, 24, 47] months after HBHCT.
Linkage to care ranged from 8.2% (95% CI, 6.8–
9.8%) [12] to 85.4% (95% CI, 75.8–92.2%) [14] when
only referral was offered, and 24.3% (95% CI, 11.8–
41.2%) [22] to 99.1% (95% CI, 96.9–99.9%) [13] when
referral plus additional interventions to facilitate linkage
were offered (Table 1). In general, linkage to care was
lower (<33%) in the studies that offered referral only
[12, 19, 21, 23, 47] and higher (>80%) in those that used
a combination of additional linkage strategies [13, 14,
18, 44].
Among seven studies that were conducted in the con-
text of a CD4 ART eligibility threshold of ≤250 cells/ll
[12, 19, 43–47], linkage to care ranged from 8.2% (95%
CI, 6.8–9.8%) [12] to 81.8% (95% CI, 71.4–89.7) [44].
Linkage was lower (<30.0%) in the studies that offered
referral only [12, 19, 47] and higher (>50%) in those that
used at least one additional linkage strategy [43–46].
Among four studies conducted in the context of a CD4
ART eligibility threshold of ≤350 cells/ll [13, 21–23],
linkage to care ranged from 24.3% (95% CI, 11.8–41.2)
[22] to 99.1% (95% CI 96.9–99.9) [13]. Linkage was
<33% in the two studies that offered referral only [21,
23]. Linkage was also low (24.3%) in one study that
used referral and POC CD4 count testing [22], but very
high (99.1%) in a study that offered referral, POC CD4
testing and additional linkage strategies [13].
Uptake of CTX prophylaxis and ART
Five studies conducted in Kenya [19], Uganda [43, 44]
and Uganda and South Africa [13, 14] had data on initia-
tion of CTX prophylaxis among eligible individuals who
linked to care. CTX prophylaxis is only recommended
for patients with CD4 count ≤200 cells/ll, WHO stage 3
or 4 or HIV/TB co-infection in South Africa [48] but is
routinely provided to all HIV-positive persons irrespective
of CD4 count or WHO disease stage in Uganda [49] and
Kenya [50]. Of the studies conducted in Uganda and
Kenya, additional interventions to facilitate referral
uptake were offered in all except one. CTX uptake in
these studies ranged from 78.2% (95% CI, 69.3–85.5%)
[13] to 100% [14, 43, 44] (Table 1). CTX uptake was
also high [90.6% (95% CI, 87.3–93.2%)] in the study
that offered referral only [19]. Interventions to facilitate
linkage were offered in the two studies that were con-
ducted in South Africa. Uptake of CTX among patients
with CD4 count ≤200 cells/ll in these studies ranged
from 0% [14] to 33.3% (95% CI, 4.3–77.7) [14].
Twelve studies [12–14, 18, 19, 21, 22, 24, 43–45, 47]
had data on ART eligibility and ART initiation among
patients who linked to care. The proportion of individu-
als eligible for ART initiation ranged from 16.5% (95%
CI, 12.1–21.8) [45] to 77.8% (95% CI, 40.0–97.2) [22]
(Table 1). ART uptake among those who linked to care
ranged from 33.0% (95% CI, 24.2–41.7%) [19] to
94.0% (95% CI, 85.4–98.3%) [47] in the studies that
provided referral only. A similar range, that is 14.3%
(95% CI, 0.36–57.9%) [22] to 94.9% (95% CI, 91.3–
97.4%) [43] was observed in the studies that provided
referral plus additional linkage interventions. ART initia-
tion rates were highest (≥90%) in the two studies in
which HIV care services were provided through commu-
nity-based research clinics [43, 47].
Discussion
Home-based HIV counselling and testing is increasingly
being used in SSA, and an effectively conducted HBHCT
strategy would be a key pre-condition for HIV control
programmes that propagate a test-and-treat approach for
HIV prevention [45]. The success of such programmes
will partly depend on their capacity to achieve high levels
of linkage to care following HIV diagnosis [16]. Hence,
it is necessary to identify and set up strategies that will
effectively link persons identified with HIV through
HBHCT to care and treatment. As observed in this
review, however, only a few studies have investigated
linkage to care among adults newly identified with HIV
through HBHCT in SSA. Linkage to care was below
© 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 817
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33% in five of six studies where participants were only
referred for care with no further interventions to facilitate
referral [12, 19, 21, 23, 47], a figure that is lower than
those for client-initiated facility-based HCT (61%) and
provider-initiated facility-based HCT (55%) [9]. With the
exception of two studies [22, 24], studies that used addi-
tional linkage strategies recorded moderate (>50% to
<80%) [43, 45, 46] to high (≥80%) [13, 14, 18, 44]
levels of linkage. These trends remained irrespective of
the CD4 ART eligibility threshold at the time of the
studies. In general, linkage to care was highest when
participants were offered POC CD4 count testing and
follow-up counselling [13, 14, 18]. These findings suggest
that HBHCT coupled with interventions to facilitate
referral uptake may achieve similar or even higher
linkage compared to facility-based HCT.
WHO recommends CTX prophylaxis for all adults
with WHO stage 3 and 4 HIV disease and/or with a
CD4 count ≤350 cells/mm3, and regardless of CD4 count
in settings where malaria and/or severe bacterial infec-
tions are highly prevalent [33]. For this reason, CTX pro-
phylaxis is an essential component of HIV care in many
settings in SSA, and its uptake may be used as an indica-
tor of access to HIV care [19, 51]. However, only a small
number of studies included in this review had data on the
uptake of CTX. In Kenya and Uganda where routine
CTX prophylaxis is recommended irrespective of CD4
count or clinical stage [49, 50], uptake was high (>70%)
irrespective of whether or not additional interventions
were applied. This may be because CTX is widely avail-
able, inexpensive and simple to use [52]. In contrast and
in spite of facilitated linkage, uptake of CTX prophylaxis
among those eligible (based on guidelines that were in
use at the time of the studies) in South Africa was low
(≤33%). The reasons for this are not clear. However, pre-
vious studies have found irregular supply and lack of
stocks of CTX, lack of awareness among healthcare
workers and perceived low priority of CTX prophylaxis
due to the absence of a reporting requirement, to be some
of the barriers to implementation of CTX prophylaxis
policies [53].
Consistent with previous findings [11], significant pro-
portions of HIV-positive persons identified through
HBHCT were still ineligible for ART (based on national
guidelines that were in use at the time of the respective
studies). The finding that ART uptake was highest in the
studies where services were provided through commu-
nity-based research clinics may be attributed to such clin-
ics being more accessible and less prone to limitations
that characterise many public sector ART care pro-
grammes in SSA, including the requirement for several
visits to prepare patients for ART [14], crowded, busy
and unwelcoming clinics [54], non-functioning laborato-
ries [54], and inadequate supply or lack of antiretroviral
drugs [55]. Additionally, some research clinics are likely
to have close and long-standing relationships with com-
munities in which they are located.
Home-based HIV counselling and testing studies with
facilitated linkage have been shown to achieve higher
ART initiation rates among participants who link to care
compared to those without facilitated linkage [9]. How-
ever, ART initiation rates were high in some but not all
studies with facilitated linkage described in this review.
Additionally, some studies without facilitated linkage
achieved higher ART initiation rates [47] than those with
facilitated linkage [13, 14, 18, 22, 24, 44, 45]. It is likely
that clinic-level factors such as those mentioned above as
well as individual-level confounding factors such as HIV
disease stage may be more important in influencing
events after linkage to care. Also, people who link to care
in the absence of facilitated linkage may be more moti-
vated to receive care.
This review has some limitations. The review was lim-
ited to SSA. Even so, the number of relevant studies
found is small and represents only six countries, four of
which are in Southern Africa. This may limit the general-
isability of the findings. The methods used in the identi-
fied studies varied widely, making it impractical to
combine findings from individual studies into a pooled
analysis. Outcome assessments in most of the included
studies were based solely on self-reports or records in
HIV clinics within the respective study areas; hence, link-
age to care may have been overestimated in the case of
self-reports or underestimated if some individuals linked
to clinics outside of their communities.
Importantly, most of the studies that included interven-
tions to facilitate linkage to HIV care were observational,
determining intervention effects without control groups.
A major limitation of observational studies is that it is
difficult to account for the effects of confounding factors
such as HIV disease stage, fear of stigma, healthcare
seeking behaviour and familiarity with the healthcare ser-
vices. Moreover, in some of the studies, two or more
interventions were delivered concurrently, making it diffi-
cult to distinguish the effects of each. Randomised trials
represent the gold-standard in evaluating an intervention
including its likely effect size [56]. It is therefore desirable
to confirm the impact and establish the cost-effectiveness
of these interventions in randomised controlled trials.
Indeed, a number of trials have been designed to investi-
gate the effect of different interventions on linkage to
care among persons that test HIV positive through
HBHCT [57–61]. Findings from these trials are expected
in the near future and may provide more robust data on
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the impact of interventions on linkage to care after
HBHCT.
Except for one study in which some of the newly iden-
tified HIV-positive individuals were offered immediate
ART irrespective of CD4 count [24], all the other studies
were conducted in the context of old ART eligibility cri-
teria, that is CD4 counts of ≤200 cells/ll, ≤250 cells/ll,
≤350 cells/ll or ≤500 cells/ll and by implication, pro-
longed pre-ART care periods. Therefore, the extent to
which the findings of this review are relevant to settings
in which the new WHO recommendation of immediate
ART initiation irrespective of CD4 count [33] has been
adopted is not clear. A future review of the evidence on
linkage to care after HBHCT under the new treatment
guidelines will be needed.
In conclusion, we found that only few published stud-
ies investigated linkage to HIV care among adults newly
diagnosed with HIV through HBHCT in SSA. In general,
HBHCT without additional intervention strategies to
increase service uptake achieved inadequate linkage,
while HBHCT combined with some kind of additional
strategy seemed to achieve higher linkage. There is a need
to confirm the impact of the most promising linkage
strategies through randomised controlled trials before
they can be recommended for large scale adoption. More-
over, it will be important to demonstrate the effectiveness
of linkage strategies under the new WHO treat-all policy.
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